Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MS
Clinical trial NCT01911377 · TERMINATED
Trial details
- NCT number
- NCT01911377
- Sponsor
- University of Manitoba
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.